Search

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that two Sloan Kettering Institute (SKI) researchers have been named 2022 Marie-Josée Kravis WISE fellowship grant recipients.

… Wednesday, March 23, 2022 Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that two Sloan Kettering Institute (SKI) researchers have been named 2022 Marie-Josée Kravis (WISE) fellowship grant recipients. The Kravis WISE Symposium is held every year during Women’s History Month in March

As long-term cancer survival outcomes improve, the brain has increasingly become a site of refractory and recurrent disease.

… Thursday, May 22, 2025 As long-term cancer survival outcomes improve, the brain has increasingly become a site of refractory and recurrent disease. At Memorial Sloan Kettering Cancer Center (MSK),  neurosurgeon Nelson Moss, MD , Co-Director of the  Multidisciplinary Brain Metastasis Program , and  radiation

Sloan Kettering Institute investigators are taking important steps toward being able to identify all the cell types in tumors. With this information, they can figure out how the cells work together.

… Thursday, June 28, 2018 Summary Sloan Kettering Institute investigators are laying the groundwork for research into the different cell types in found in and around tumors. The composition of malignant tumors is incredibly complex. They contain not only cancer cells but also dozens of other cell types

MSK Kids doctors report advances in treating pediatric cancers at the 2019 meeting of the American Society of Clinical Oncology.

… Monday, June 3, 2019 Summary At the 2019 annual meeting of the American Society of Clinical Oncology, MSK Kids pediatric experts presented updates on the treatment of cancer in children, including encouraging news on targeted therapies and a promising drug-delivery technique for a rare brain tumor. This

Free, virtual programs in English and Spanish for our community.

… Thursday, April 8, 2021 In honor of Minority Cancer Awareness Month , MSK is pleased to offer the following free, virtual programs to our community. To register for these events, please visit: https://bit.ly/3cyvhqc Understanding Your Health Insurance Monday, April 12, 2021, 4:00– 5:00 p.m. EST Understanding

Dr. Miguel-Angel Perales explains why MSK has continued to be a leader in the field of stem cell and bone marrow transplantation for more than 50 years.

… Friday, January 9, 2026 Patients with leukemia , lymphoma , multiple myeloma , amyloidosis , and myelodysplastic syndrome often need a  stem cell transplant (also known as bone marrow transplant, or BMT) to treat their blood cancer. Patients with other blood disorders like aplastic anemia, sickle cell

Discover how exercise can reduce the long-term risk of cardiovascular disease in women with early-stage breast cancer.

… Thursday, June 2, 2016 Summary A study from Memorial Sloan Kettering exercise scientist Lee Jones shows that women with early-stage breast cancer can reduce their risk of long-term heart problems with exercise. Cardiovascular disease is the leading cause of side effects and early death in these patients

Fifty years ago, the signing of the National Cancer Act ushered in a new era of cancer research and care.

… Thursday, May 27, 2021 Fifty years ago, the signing of the National Cancer Act launched the nation’s “War on Cancer” and ushered in a new era of cancer research and care. The legislation inspired a national commitment to making progress against cancer, the second leading cause of death in the U.S. In

The April 29 session of “MSK Science Spotlight” will feature a lecture from newly elected member of the National Academy of Sciences (NAS), Scott Keeney, PhD.

… Wednesday, April 29, 2020 The April 29 session of “ MSK Science Spotlight ” will feature a lecture from newly elected member of the National Academy of Sciences (NAS), Scott Keeney, PhD . Dr. Keeney, a molecular biologist at SKI, investigates mechanisms of the initiation of meiotic recombination. His

MSK received top rankings in gynecology, urology, and several subspecialties

… Tuesday, July 27, 2021 Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the number two hospital for cancer care in the nation by U.S. News & World Report in its annual Best Hospitals listing. Since these prestigious rankings were established more than 30 years ago, MSK has consistently